Published in Zh Mikrobiol Epidemiol Immunobiol on September 22, 1994
Development of a diagnostic test for Yersinia pestis by the polymerase chain reaction. J Appl Bacteriol (1994) 1.28
Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits. Vaccine (2003) 0.96
Toll-Like Receptors (TLRs): The Role in Tumor Progression. Acta Naturae (2010) 0.91
Non-thermal Plasma Causes p53-Dependent Apoptosis in Human Colon Carcinoma Cells. Acta Naturae (2012) 0.89
Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 Virus. Acta Naturae (2010) 0.88
[Influence of environmental factors on the expression of Mycoplasma pneumoniae gene responsible for the synthesis of protein P1 adhesion]. Zh Mikrobiol Epidemiol Immunobiol (2003) 0.86
[Biofilms as a mode of existence of bacteria in external environment and host body: the phenomenon, genetic control, and regulation systems of development]. Genetika (2004) 0.85
[An outbreak of acute respiratory infections among adults caused by adenovirus serotype 14]. Vopr Virusol (1969) 0.85
[Genetic control of the induction of a nonculturable state in pathogenic bacteria]. Zh Mikrobiol Epidemiol Immunobiol (1996) 0.85
Development of Chlamydial Type III Secretion System Inhibitors for Suppression of Acute and Chronic Forms of Chlamydial Infection. Acta Naturae (2012) 0.82
[Analysis of the plasmid composition of Yersinia pseudotuberculosis strains and its use for typing pseudotuberculosis pathogens]. Mol Gen Mikrobiol Virusol (1989) 0.82
[Detection of the genes of pyrogenic toxins of superantigens in clinical isolates of methicillin resistant Staphylococcus aureus]. Zh Mikrobiol Epidemiol Immunobiol (2006) 0.81
Prevalence of genes encoding exfoliative toxins among Staphylococcus hyicus isolated in Russia and Germany. J Vet Med B Infect Dis Vet Public Health (2006) 0.81
[Prospects for the use of low-temperature gas plasma as an antimicrobial agent]. Vestn Ross Akad Med Nauk (2011) 0.81
Recombinant influenza vaccines. Acta Naturae (2012) 0.80
[The possibility of preserving the causative agent of plague in soil in resting (nonculturable) form]. Zh Mikrobiol Epidemiol Immunobiol (1997) 0.80
[Creation of specialized transducing lambda phages bearing RNA-polymerase genes]. Genetika (1976) 0.80
[Target-directed search of anti-virulence drugs]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.80
[Comparative evaluation of the efficacy of Borrelia indication in ixodes ticks (Ixodidae) using dark field microscopy and polymerase chain reaction (PCR)]. Parazitologiia (2001) 0.79
[Type III bacterial secretion system, a promising target for the development of a new generation of antibiotic drugs]. Vestn Ross Akad Med Nauk (2008) 0.79
[A study of the prevalence of regulatory genes controlling virulence gene expression among Vibrio choleraeeltor biovariant strains varying in their pandemic potential]. Mol Gen Mikrobiol Virusol (2007) 0.78
[Effector proteins of Clamidia]. Mol Biol (Mosk) (2010) 0.78
Transcription termination factor rho and T-even phage development. Mol Gen Genet (1980) 0.78
An Efficient Method for the Delivery of the Interleukin-2 Gene to Human Hematopoietic Cells using the Fiber-Modified Recombinant Adenovirus. Acta Naturae (2011) 0.78
A In Vitro and In Vivo Study of the Ability of NOD1 Ligands to Activate the Transcriptional Factor NF-kB. Acta Naturae (2011) 0.78
[Formation of biofilms as an example of the social behavior of bacteria]. Mikrobiologiia (2006) 0.77
[Construction of the vector based on the CELO avian adenovirus genome providing enhanced expression of secreted alkaline phosphatase gene in a non-permissive system in vitro and in vivo]. Mol Gen Mikrobiol Virusol (2008) 0.77
Toll-like receptors and their adapter molecules. Biochemistry (Mosc) (2010) 0.77
[The induction of protective immune response in mice vaccinated by recombinant avian adenovirus CELO expressing glycoprotein G of the rabies virus]. Zh Mikrobiol Epidemiol Immunobiol (2006) 0.77
[Structural-functional characteristics of Yersinia pseudotuberculosis plasmid pVM82]. Genetika (1990) 0.77
[Mobile ISCR elements: structure, functions, and role in the emergence, increasing and spreading of blocks of bacterial genes of multiple antibiotic resistance]. Mol Gen Mikrobiol Virusol (2012) 0.77
[Isolation and phenotyping of Vibrio cholerae strains with the enhanced production of main protective antigens]. Zh Mikrobiol Epidemiol Immunobiol (2001) 0.77
[Correlation between activity of the phosphoenol-pyruvate-dependable phosphotransferase system (PTS) and synthesis of adhesion P1 protein in Mycoplasma pneumoniae]. Mol Gen Mikrobiol Virusol (2003) 0.77
[Wild small mammals are the reservoir hosts of the Bartonella genus bacteria in the south of Moscow region]. Mol Gen Mikrobiol Virusol (2006) 0.77
[Comparative analysis of the major protective antigens production in Vibrio cholerae recombinant and producer strains of the classical biovar]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.77
[Genomic variability of vibrio cholerae El Tor biovariant strains]. Vestn Ross Akad Med Nauk (2005) 0.77
[Protective properties of candidate genetically engineered vaccines against avian influenza viruses constructed on the basis of recombinant adenoviral vectors]. Zh Mikrobiol Epidemiol Immunobiol (2010) 0.77
[Some immunochemical and immunobiological properties of Vibrio cholerae serovar 0139 capsule antigen]. Mol Gen Mikrobiol Virusol (1997) 0.77
[Role of apoptosis in the regulation of the infectious process]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.77
Effective Genetic Expression of Nanoantibodies by Recombinant Adenoviral Vector in vitro. Acta Naturae (2011) 0.76
[Nonculturable forms of Yersinia pseudotuberculosis in the soils of a natural focus of pseudotuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (1997) 0.76
[Strains of Vibrio cholerae serogroups O1 and O139 that produce the basic protective antigens]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.76
[Smallpox is a dormant volcano]. Vopr Virusol (2008) 0.76
[Production of mycobacterial antigenes merged with cellulose binding protein domain in order to produce subunit vaccines against tuberculosis]. Mol Gen Mikrobiol Virusol (2012) 0.76
Virulence-associated characteristics and phage lysogenicity of two morphologically distinct colonies of Vibrio cholerae O139 serogroup. FEMS Microbiol Lett (1996) 0.76
[Virulent properties of hospital strains of bacteria of the Burkholderia cepacia complex, isolated in hospitals of Moscow]. Zh Mikrobiol Epidemiol Immunobiol (2006) 0.76
[An avirulent vibrio cholerae strain--producer of the cholera toxin B subunit: obtaining and molecular genetic analysis]. Mol Gen Mikrobiol Virusol (2007) 0.76
[A new pathogenic trait encoded by Yersinia pseudotuberculosis pVM82 plasmid]. Genetika (1988) 0.76
[Prophage CTXphi genome variability and its role in alteration of Vibrio cholerae El Tor virulence characteristics]. Zh Mikrobiol Epidemiol Immunobiol (2008) 0.75
[A new R-plasmid from Yersinia pseudotuberculosis]. Mol Gen Mikrobiol Virusol (1992) 0.75
["Quorum sensing" or social behavior of bacteria]. Zh Mikrobiol Epidemiol Immunobiol (2003) 0.75
[Prevention of complications in combined (laser and extrascleral) treatment of retinal detachment]. Vestn Oftalmol (2004) 0.75
[Genetic control of the formation of plasmid F'. I. Effect of recA- and seg-2 mutations in an Hfr donor strain on the character of plasmid F' formation]. Genetika (1979) 0.75
[Study of antimutagenic properties of bio-ginseng in mammalian cells in vitro and in vivo]. Biull Eksp Biol Med (1991) 0.75
[Independence of the processes of transposition and genome rearrangements induced by transposons]. Genetika (1983) 0.75
[Effect of the dose of ptsI- and ptsH-genes on carbohydrate transport and regulation of lac-operon activity in Escherichia coli K-12]. Genetika (1979) 0.75
[Adhesins from Vibrio cholerae: phenotypic analysis and genetic control of synthesis]. Mol Gen Mikrobiol Virusol (1995) 0.75
[Phenotypic features of a strain of Yersinia pseudotuberculosis with the pVM82 plasmid, detected at pseudotuberculosis outbreak foci]. Mol Gen Mikrobiol Virusol (1991) 0.75
[Bacterial superintegrons, a source of new genes with adaptive functions]. Genetika (2006) 0.75
[Use of transposons for studying the genetic organization of Vibrio cholerae non 01]. Mol Gen Mikrobiol Virusol (1991) 0.75
[Genetic analysis of Vibrio cholerae chromosomal regions containing the tox-2 mutation, affecting production of cholera toxin]. Mol Gen Mikrobiol Virusol (1996) 0.75
[Mapping a genetic determinant determining the increased synthesis of cholera toxin by the Dakka 35 strain of Vibrio cholerae]. Mol Gen Mikrobiol Virusol (1994) 0.75
[Scleroplasty in the treatment of progressive myopia]. Vestn Oftalmol (1972) 0.75
[Primary mapping of the Oag locus determining the synthesis of the somatic O-antigen on the Vibrio eltor chromosome]. Genetika (1982) 0.75
[Laser cyclodestructive procedures in glaucoma treatment]. Vestn Oftalmol (2012) 0.75
[Construction of a genetic map of the chromosome of Vibrio cholerae based on conjugational crossings]. Genetika (1985) 0.75
[Communication systems in bacteria and their role in pathogenicity]. Mol Gen Mikrobiol Virusol (2006) 0.75
[Genetic study of plasmid pVM82 which contributes to the pathogenicity of the pseudotuberculosis pathogen]. Genetika (1995) 0.75
[Emergence of toxigenic Vibrio cholerae strains on non-O1 serotype as a result of the exchange of genetic information]. Genetika (1996) 0.75
[Mobile genetic elements and their role in evolution of pathogenic bacteria]. Vestn Ross Akad Med Nauk (2001) 0.75
[A new type of potentially mobile genetic elements--integrons, assuring site-specific introduction of DNA modules with resistance genes, and expression of them]. Mol Gen Mikrobiol Virusol (1993) 0.75
[Laser treatment of primary open-angle glaucoma. Randomized comparative studies. Cyclotrabeculospasis and trabeculoplasty]. Vestn Oftalmol (1983) 0.75
[Noncapsular mutants of Vibrio cholerae serogroup O139: their isolation, identification and use for the preparation of an O139 diagnostic antiserum]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.75
[Specificity of introducing the transposon that determines chloramphenicol resistance (Tn9) into the chromosome of Escherichia coli K-12]. Genetika (1978) 0.75
[Role of lysogenizing phages in the spread of drug-resistance plasmids in a staphylococcal population]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75
[The outlook for the use of diode laser radiation for trabeculoplasty in treating primary open-angle glaucoma]. Vestn Oftalmol (1999) 0.75
[Alternative of laser treatment optimization in retinoschisis]. Vestn Oftalmol (2011) 0.75
[Interaction of bacteria of the genus Bartonella with the host: inhibition of apoptosis, induction of proliferation, and formation of tumors]. Mol Gen Mikrobiol Virusol (2008) 0.75
[Influence of iridial anatomic and structural characteristics on the choice of the optimum laser interventions in the treatment of glaucomas]. Vestn Oftalmol (2007) 0.75
[Efficiency of laser coagulation in the treatment of rhegmatogenous retinal detachment]. Vestn Oftalmol (2011) 0.75
[Current techniques of laser therapy in glaucoma]. Vestn Oftalmol (2003) 0.75
[Creating a system of conjugated chromosome transfer and genetic mapping of Vibrio cholerae serogroup O139 chromosomes]. Mol Gen Mikrobiol Virusol (1996) 0.75
[Tn9 integration sites and their effect on transposon properties]. Genetika (1980) 0.75
[Genetic control of Vibrio cholerae pathogenicity: the temperate filamentous phage CTX, coding for cholera toxin and the "island of pathogenicity"]. Mol Gen Mikrobiol Virusol (1999) 0.75
[Vibrio eltor mutants with altered hemolysin production: their isolation and characteristics]. Genetika (1982) 0.75
[Role of changes in chorioretinal structures in the mechanism of the therapeutic effect of argon lasers (experimental study)]. Vestn Oftalmol (1982) 0.75
[Laser treatment of early postoperative complications in glaucoma]. Vestn Oftalmol (1985) 0.75
[Repression of the enzyme inducible syntheses in Escherichia coli K12 mutant with a deleted ptsH gene]. Mol Biol (Mosk) (1979) 0.75
[Use of R plasmids for isolating Vibrio cholerae donor strains]. Genetika (1984) 0.75
[The capacity to produce cholera exotoxin in natural strains of Vibrio cholerae]. Zh Mikrobiol Epidemiol Immunobiol (1990) 0.75
[Genetic analysis of the Mud mutants of Escherichia coli K-12 with an impaired ability to maintain bacteriophage Mu development]. Genetika (1984) 0.75
[Phenotypic analysis of two morphologically different types of Vibrio cholerae 0139 colonies]. Mol Gen Mikrobiol Virusol (1995) 0.75
[Vibrio cholerae temperate phage O139: characteristics and role in changing expression of chromosomal virulence genes]. Mol Gen Mikrobiol Virusol (1999) 0.75